Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma

Ming-Zhu Liu; Xian-Shu Gao; Shang-Bin Qin; Xiao-Ying Li; Ming-Wei Ma; Mu Xie; Feng Lyu; Dian Wang

doi:10.21037/tau-21-291

Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma

Transl Androl Urol. 2021 Jul;10(7):2929-2937. doi: 10.21037/tau-21-291.

Authors

Ming-Zhu Liu¹, Xian-Shu Gao¹, Shang-Bin Qin¹, Xiao-Ying Li¹, Ming-Wei Ma¹, Mu Xie¹, Feng Lyu¹, Dian Wang²

Affiliations

¹ Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
² Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.

Abstract

Background: The standard management for upper urinary tract urothelial carcinoma (UTUC) is radical nephroureterectomy (RNU). However, some patients cannot undergo this procedure for several reasons, such as unresectable disease, old age, and multiple comorbidities. Our study explored the potential safety and effectiveness of radiotherapy as a curative treatment for UTUC patients unfit for surgery.

Methods: The data of patients treated with radiotherapy between December 2017 and November 2019 were retrospectively reviewed. For the literature review, computerized PubMed Medline, Index Medicus, and Web of Science databases and reference lists from the identified publications of interest were used. And "upper-tract urothelial carcinoma" and "radiotherapy" were used as key words in the search.

Results: We describe 8 patients with UTUC who were treated with radiotherapy. The median follow-up time was 13.5 months (range, 8.6-30.9 months). Local tumor control was achieved in all patients. However, distant metastases were observed in 2 patients with T3-4/N+ status. One patient had T4 status and the other had N2+ status. The patients died of tumor progression at 15.0 and 17.7 months. In addition, the other 6 patients who were still alive had relatively early-stage tumors without nodal involvement. Regarding acute toxicity, according to the CTCAE v5.0, mild side effects were noted, including grade 1 nausea and diarrhea. Four patients developed mild anemia, generally of grade 1-2. One patient experienced grade 3 anemia, but it was manageable and improved with symptomatic support. In addition, no grade 4 acute or late toxicities were observed. No significant long-term impairment of renal function occurred.

Conclusions: For patients with nonmetastatic UTUC who are not suitable for surgery, radiotherapy is a safe treatment and can achieve good local tumor control.

Keywords: Upper urinary tract urothelial carcinoma (UTUC); inoperable; nonmetastatic; radiation therapy.